SOURCE: Swedish-American Life Science Summit

August 17, 2005 12:30 ET

Leading International Life Science Investors Converge at the Swedish-American Life Science Summit in Stockholm, Sweden on August 24 and 25

Mr. Frederick Frank, Vice Chairman, Lehman Brothers, Dr. William Haseltine, Founder of Human Genome Sciences, Inc., Mr. Jordan Schreiber, Head of Merrill Lynch Healthcare Fund and Mr. Carl Bildt, Former Prime Minister of Sweden and Chairman of the Kreab Group Among the Speakers

STOCKHOLM, SWEDEN -- (MARKET WIRE) -- August 17, 2005 -- The organizers of the Swedish-American Life Science Summit 2005 today announced the final details on the Life Science Summit, which takes place in Stockholm, Sweden on August 24 and 25.

The Summit will take place at the headquarters of the Kreab Group and will be moderated by Mr. Udayan Gupta, former Venture Capital Editor for the Wall Street Journal. It will offer a broad overview as well as in-depth analysis of the field of Swedish-American Life Science investments, covering both companies and technologies, and focusing in particular on changes in international investment strategies and collaboration methods.

Confirmed speakers include: Mr. Magnus Lundberg, CEO, Pharmacia Diagnostics, Mr. William Gedale, Managing General Partner, NGN Capital, Mr. Mats Pettersson, CEO, Biovitrum, Dr. John Wilkerson, Chairman and General Partner, Galen Partners L.P., Mr. Olle Johansson, CEO, LinkMed AB, Dr. Yuval Binur, Chairman, Accelerated Technologies and General Partner, Medica Venture Partners, Dr. Viktor Drvota, Head of Life Science investments, SEB Foretagsinvest and Professor Mathias Uhlén, KTH Biotechnology.

50 specially invited industry executives and investors will be attending.

Ms. Barbro Ehnbom, President of Du Haan Groupe, Inc. representing the organizers of the summit, issued the following statement: "We are very pleased to be able to host several of the world's foremost authorities on life science investments at this exclusive gathering in Stockholm. It is our hope and ambition that the summit will serve to increase the amount of cross-border business between the largest market in the world, the United States, and one of the most important Life Science industry centers in Europe, Sweden."

Detailed information about the Swedish-American Life Science Summit, 2005 can be found at www.swedishamericanlifescience.com

The Summit is a private initiative organized in cooperation with, among other partners: Active Biotech, Cellectricon, SEB Foretagsinvest, Enskilda Securities, Invest in Sweden Agency, Merrill Lynch, Lehman Brothers, Hultén Reklambyra, LinkMed, AnaMar, White & Case, EIM, the US Embassy, the Kreab Group, Stone Wall Partners and Pfizer.

Contact Information

  • Media Contact:
    Mr. Magnus Gink
    Phone: + 46 709 997689
    Email Contact